Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

New Handheld Raman Spectrometer Provides Portable Pharmaceutical Analysis

Published: Monday, November 18, 2013
Last Updated: Monday, November 18, 2013
Bookmark and Share
Thermo Scientific TruScan GP allows for quick, easy chemical identification.

Pharmaceutical manufacturers and regulatory agencies around the world can use a new, cost-effective handheld Raman analyzer to quickly identify raw materials and confirm the authenticity of finished products. The Thermo Scientific TruScan GP offers pharmaceutical identification capabilities for pharmaceutical manufacturers in emerging markets.

“Our objective is to provide reliable chemical identification to more manufacturers and governments around the globe,” said Bob Brush, business development manager, Thermo Fisher Scientific. “The purpose-built, point and shoot TruScan GP is designed to allow more users to accurately identify inconsistencies in materials right away, saving time and money down the line in the manufacturing process as well as in the field of counterfeit screening.”

The TruScan GP analyzer features a patented probabilistic approach to material identification and is designed to assist users to meet a wide variety of regulatory compliance needs within the chemical screening market. The user-built chemical library enables customers to tailor the instrument to meet their specific screening objectives. 

The TruScan GP also offers the following key benefits: 

• Easy to operate, simplified workflow requiring only a few minutes of basic operating instruction;

• Patented algorithmic approach to raw material and finished product identification, allowing users to customize library development and validation inclusive of compliance requirements such as specificity and robustness;

• Portable size and rapid, on-board result reporting designed for effective field-based screening;

• Secure connectivity to archives designed to promote data integrity as well as automatic generation of audit trails and test reports.

The instrument employs Raman spectroscopy, a preferred laser-based analytical technique for pharmaceutical quality control, which works by detecting frequencies of light highly specific to the molecular structure of different liquids and solids. The purpose-built, streamlined, point-and-shoot device is a competitively priced, fully capable identification solution.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Extends Collaboration with University of Birmingham
New Phenome Centre Birmingham, UK to use Thermo Scientific mass spectrometry instruments to advance metabolic phenotyping and metabolomics studies.
Tuesday, May 24, 2016
Thermo Fisher Completes Acquisition of Alfa Aesar
Thermo Fisher Scientific the world leader in serving science, has completed its previously announced acquisition of Alfa Aesar, a leading global manufacturer of research chemicals, from Johnson Matthey Plc, for £256 million (or approximately $400 million) in cash.
Friday, October 02, 2015
Thermo Fisher Scientific and Newman-Lakka Institute to Collaborate
The collaboration will research diagnostic approaches for personalized cancer treatment.
Tuesday, June 25, 2013
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
New Strategy for Choosing Cancer Drugs
Device can predict tumor responses by measuring cell growth after drug exposure.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos